Southport Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CI
Southport Capital Management's IBB Position: Q3 2016 in Review
Southport Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 327 shares — an estimated $28K sold.
Southport Capital Management first reported a position in IBB in Q2 2016 and held it in 1 quarter. The position peaked at $28K in Q2 2016. 463 funds tracked by Wall St. Rank hold IBB as of Q3 2016.
- Southport Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
- Southport Capital Management sold 327 iShares Biotechnology ETF shares in Q3 2016, an estimated $28K.
- Southport Capital Management first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 1 quarter.
- Southport Capital Management's iShares Biotechnology ETF position peaked at $28K in Q2 2016.
- 463 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.
Based on Southport Capital Management's 13F filing for Q3 2016, filed 19 Oct 2016.